ACS Publications. Most Trusted. Most Cited. Most Read
My Activity

Figure 1Loading Img

Quantitative Targeted Absolute Proteomic Analysis of Transporters, Receptors and Junction Proteins for Validation of Human Cerebral Microvascular Endothelial Cell Line hCMEC/D3 as a Human Blood–Brain Barrier Model

View Author Information
Division of Membrane Transport and Drug Targeting, Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Japan
Department of Pharmaceutical Microbiology, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan
§ INSERM, U1016, Institut Cochin, Paris, France
CNRS, UMR8104, Paris, France
Université Paris Descartes, Paris, France
# Neuropsychopharmacologie des addictions (CNRS UMR 8206), Université Paris Descartes, Faculté de Pharmacie, Paris, France
INSERM U705, Neuropsychopharmacologie des addictions, Paris, France
*Division of Membrane Transport and Drug Targeting, Graduate School of Pharmaceutical Sciences, Tohoku University, 6-3 Aoba, Aramaki, Aoba-ku, Sendai 980-8578, Japan. Tel: +81-22-795-6831. Fax: +81-22-795-6886. E-mail: [email protected]
Cite this: Mol. Pharmaceutics 2013, 10, 1, 289–296
Publication Date (Web):November 8, 2012
Copyright © 2012 American Chemical Society

    Article Views





    Other access options


    Abstract Image

    Human cerebral microvascular endothelial cell line hCMEC/D3 is an established model of the human blood–brain barrier (BBB). The purpose of the present study was to determine, by means of quantitative targeted absolute proteomics, the protein expression levels in hCMEC/D3 cells of multiple transporters, receptors and junction proteins for comparison with our previously reported findings in isolated human brain microvessels. Among 91 target molecules, 12 transporters, 2 receptors, 1 junction protein and 1 membrane marker were present at quantifiable levels in plasma membrane fraction of hCMEC/D3 cells. ABCA2, MDR1, MRP4, BCRP, GLUT1, 4F2hc, MCT1, ENT1, transferrin and insulin receptors and claudin-5 were detected in both hCMEC/D3 cells and human brain microvessels. After normalization based on Na+/K+ ATPase expression, the differences in protein expression levels between hCMEC/D3 cells and human brain microvessels were within 4-fold for these proteins, with the exceptions of ENT1, transferrin receptor and claudin-5. ABCA8, LAT1, LRP1 and γ-GTP were below the limit of quantification in the cells, but were found in human brain microvessels. ABCA3, ABCA6, MRP1 and ATA1 were found only in hCMEC/D3 cells. Furthermore, compared with human umbilical vein endothelial cells (HUVECs) as reference nonbrain endothelial cells, MDR1 was found only in hCMEC/D3 cells, and GLUT1 expression was 15-fold higher in hCMEC/D3 cells than in HUVECs. In conclusion, this is the first study to examine the suitability and limitations of the hCMEC/D3 cell line as a BBB functional model in terms of quantitative expression levels of transporters, receptors and tight junction proteins.

    Read this article

    To access this article, please review the available access options below.

    Get instant access

    Purchase Access

    Read this article for 48 hours. Check out below using your ACS ID or as a guest.


    Access through Your Institution

    You may have access to this article through your institution.

    Your institution does not have access to this content. You can change your affiliated institution below.

    Cited By

    This article is cited by 179 publications.

    1. Ryotaro Yagi, Takeshi Masuda, Seiryo Ogata, Ayano Mori, Shingo Ito, Sumio Ohtsuki. Proteomic Evaluation of Plasma Membrane Fraction Prepared from a Mouse Liver and Kidney Using a Bead Homogenizer: Enrichment of Drug-Related Transporter Proteins. Molecular Pharmaceutics 2020, 17 (11) , 4101-4113.
    2. Elena Puris, Mikko Gynther, Elizabeth C.M. de Lange, Seppo Auriola, Margareta Hammarlund-Udenaes, Kristiina M. Huttunen, Irena Loryan. Mechanistic Study on the Use of the l-Type Amino Acid Transporter 1 for Brain Intracellular Delivery of Ketoprofen via Prodrug: A Novel Approach Supporting the Development of Prodrugs for Intracellular Targets. Molecular Pharmaceutics 2019, 16 (7) , 3261-3274.
    3. Takeshi Masuda, Toshiki Hoshiyama, Tatsuki Uemura, Mio Hirayama-Kurogi, Seiryo Ogata, Arisu Furukawa, Pierre-Olivier Couraud, Tomomi Furihata, Shingo Ito, Sumio Ohtsuki. Large-Scale Quantitative Comparison of Plasma Transmembrane Proteins between Two Human Blood–Brain Barrier Model Cell Lines, hCMEC/D3 and HBMEC/ciβ. Molecular Pharmaceutics 2019, 16 (5) , 2162-2171.
    4. Huilong Luo, Elisa Rossi, Bruno Saubamea, Stéphanie Chasseigneaux, Véronique Cochois, Nina Choublier, Maria Smirnova, Fabienne Glacial, Nicolas Perrière, Sandrine Bourdoulous, David M. Smadja, Marie-Claude Menet, Pierre-Olivier Couraud, Salvatore Cisternino, Xavier Declèves. Cannabidiol Increases Proliferation, Migration, Tubulogenesis, and Integrity of Human Brain Endothelial Cells through TRPV2 Activation. Molecular Pharmaceutics 2019, 16 (3) , 1312-1326.
    5. Kazuki Sato, Masanori Tachikawa, Michitoshi Watanabe, Eisuke Miyauchi, Yasuo Uchida, Tetsuya Terasaki. Identification of Blood–Brain Barrier-Permeable Proteins Derived from a Peripheral Organ: In Vivo and in Vitro Evidence of Blood-to-Brain Transport of Creatine Kinase. Molecular Pharmaceutics 2019, 16 (1) , 247-257.
    6. Hiroki Kuroda, Masanori Tachikawa, Yuta Yagi, Mina Umetsu, Armania Nurdin, Eisuke Miyauchi, Michitoshi Watanabe, Yasuo Uchida, Tetsuya Terasaki. Cluster of Differentiation 46 Is the Major Receptor in Human Blood–Brain Barrier Endothelial Cells for Uptake of Exosomes Derived from Brain-Metastatic Melanoma Cells (SK-Mel-28). Molecular Pharmaceutics 2019, 16 (1) , 292-304.
    7. Toshiki Kurosawa, Yuma Tega, Kei Higuchi, Tomoko Yamaguchi, Takashi Nakakura, Tatsuki Mochizuki, Hiroyuki Kusuhara, Kenji Kawabata, Yoshiharu Deguchi. Expression and Functional Characterization of Drug Transporters in Brain Microvascular Endothelial Cells Derived from Human Induced Pluripotent Stem Cells. Molecular Pharmaceutics 2018, 15 (12) , 5546-5555.
    8. Huilong Luo, Matthieu Gauthier, Xi Tan, Christophe Landry, Joël Poupon, Marie-Pierre Dehouck, Fabien Gosselet, Nicolas Perrière, Frank Bellivier, Salvatore Cisternino, Xavier Declèves. Sodium Transporters Are Involved in Lithium Influx in Brain Endothelial Cells. Molecular Pharmaceutics 2018, 15 (7) , 2528-2538.
    9. Zhengyu Zhang, Masanori Tachikawa, Yasuo Uchida, Tetsuya Terasaki. Drug Clearance from Cerebrospinal Fluid Mediated by Organic Anion Transporters 1 (Slc22a6) and 3 (Slc22a8) at Arachnoid Membrane of Rats. Molecular Pharmaceutics 2018, 15 (3) , 911-922.
    10. Christine Wegler, Fabienne Z. Gaugaz, Tommy B. Andersson, Jacek R. Wiśniewski, Diana Busch, Christian Gröer, Stefan Oswald, Agneta Norén, Frederik Weiss, Helen S. Hammer, Thomas O. Joos, Oliver Poetz, Brahim Achour, Amin Rostami-Hodjegan, Evita van de Steeg, Heleen M. Wortelboer, and Per Artursson . Variability in Mass Spectrometry-based Quantification of Clinically Relevant Drug Transporters and Drug Metabolizing Enzymes. Molecular Pharmaceutics 2017, 14 (9) , 3142-3151.
    11. Laura Pelkonen, Kazuki Sato, Mika Reinisalo, Heidi Kidron, Masanori Tachikawa, Michitoshi Watanabe, Yasuo Uchida, Arto Urtti, and Tetsuya Terasaki . LC–MS/MS Based Quantitation of ABC and SLC Transporter Proteins in Plasma Membranes of Cultured Primary Human Retinal Pigment Epithelium Cells and Immortalized ARPE19 Cell Line. Molecular Pharmaceutics 2017, 14 (3) , 605-613.
    12. Paul A. Clark, Abraham J. Al-Ahmad, Tongcheng Qian, Ray R. Zhang, Hannah K. Wilson, Jamey P. Weichert, Sean P. Palecek, John S. Kuo, and Eric V. Shusta . Analysis of Cancer-Targeting Alkylphosphocholine Analogue Permeability Characteristics Using a Human Induced Pluripotent Stem Cell Blood–Brain Barrier Model. Molecular Pharmaceutics 2016, 13 (9) , 3341-3349.
    13. Takanori Akazawa, Yasuo Uchida, Masanori Tachikawa, Sumio Ohtsuki, and Tetsuya Terasaki . Quantitative Targeted Absolute Proteomics of Transporters and Pharmacoproteomics-Based Reconstruction of P-Glycoprotein Function in Mouse Small Intestine. Molecular Pharmaceutics 2016, 13 (7) , 2443-2456.
    14. Fei Liu, Michael Koval, Shoba Ranganathan, Susan Fanayan, William S. Hancock, Emma K. Lundberg, Ronald C. Beavis, Lydie Lane, Paula Duek, Leon McQuade, Neil L. Kelleher, and Mark S. Baker . Systems Proteomics View of the Endogenous Human Claudin Protein Family. Journal of Proteome Research 2016, 15 (2) , 339-359.
    15. Alice Gaudin, Oya Tagit, Dunja Sobot, Sinda Lepetre-Mouelhi, Julie Mougin, Thomas F. Martens, Kevin Braeckmans, Valérie Nicolas, Didier Desmaële, Stefaan C. de Smedt, Niko Hildebrandt, Patrick Couvreur, and Karine Andrieux . Transport Mechanisms of Squalenoyl-Adenosine Nanoparticles Across the Blood–Brain Barrier. Chemistry of Materials 2015, 27 (10) , 3636-3647.
    16. Anna Nilsson, Richard J. A. Goodwin, Mohammadreza Shariatgorji, Theodosia Vallianatou, Peter J. H. Webborn, and Per E. Andrén . Mass Spectrometry Imaging in Drug Development. Analytical Chemistry 2015, 87 (3) , 1437-1455.
    17. Ana Rita Monteiro, Daniel José Barbosa, Fernando Remião, Renata Silva. Co-Culture Models: Key Players in In Vitro Neurotoxicity, Neurodegeneration and BBB Modeling Studies. Biomedicines 2024, 12 (3) , 626.
    18. Sabrina Petralla, Liudmila Saveleva, Katja M. Kanninen, Julia S. Oster, Maria Panayotova, Gert Fricker, Elena Puris. Increased Expression of Transferrin Receptor 1 in the Brain Cortex of 5xFAD Mouse Model of Alzheimer’s Disease Is Associated with Activation of HIF-1 Signaling Pathway. Molecular Neurobiology 2024, 29
    19. Nicholas G. Lamson, Andrew J. Pickering, Jeffrey Wyckoff, Priya Ganesh, Elizabeth A. Calle, Joelle P. Straehla, Paula T. Hammond. Trafficking through the blood–brain barrier is directed by core and outer surface components of layer‐by‐layer nanoparticles. Bioengineering & Translational Medicine 2023,
    20. Shingo Ito, Ryotaro Yagi, Seiryo Ogata, Takeshi Masuda, Takashi Saito, Takaomi Saido, Sumio Ohtsuki. Proteomic alterations in the brain and blood–brain barrier during brain Aβ accumulation in an APP knock-in mouse model of Alzheimer’s disease. Fluids and Barriers of the CNS 2023, 20 (1)
    21. Tomoko Yamaguchi, Daiki Sako, Toshiki Kurosawa, Misae Nishijima, Ayaka Miyano, Yoshiyuki Kubo, Sumio Ohtsuki, Kenji Kawabata, Yoshiharu Deguchi. Development and Functional Evaluation of MDR1-expressing Microvascular Endothelial-like Cells Derived from Human iPS Cells as an In vitro Blood-brain Barrier Model. Journal of Pharmaceutical Sciences 2023, 112 (12) , 3216-3223.
    22. Zengtao Wang, Nidhi Sharda, Rajesh S. Omtri, Ling Li, Karunya K. Kandimalla. Amyloid-Beta Peptides 40 and 42 Employ Distinct Molecular Pathways for Cell Entry and Intracellular Transit at the Blood–Brain Barrier Endothelium. Molecular Pharmacology 2023, 104 (5) , 203-213.
    23. Lucia Zakharova, Gulnara Gaynanova, Elmira Vasilieva, Leysan Vasileva, Rais Pavlov, Ruslan Kashapov, Konstantin Petrov, Oleg Sinyashin. Recent Nanoscale Carriers for Therapy of Alzheimer's Disease: Current Strategies and Perspectives. Current Medicinal Chemistry 2023, 30 (33) , 3743-3774.
    24. Sevda T. Boyanova, Ethlyn Lloyd-Morris, Christopher Corpe, Khondaker Miraz Rahman, Doaa B. Farag, Lee K. Page, Hao Wang, Alice L. Fleckney, Ariana Gatt, Claire Troakes, Gema Vizcay-Barrena, Roland Fleck, Suzanne J. Reeves, Sarah A. Thomas, . Interaction of amisulpride with GLUT1 at the blood-brain barrier. Relevance to Alzheimer’s disease. PLOS ONE 2023, 18 (10) , e0286278.
    25. Md Masud Parvez, Armin Sadighi, Yeseul Ahn, Steve F. Keller, Julius O. Enoru. Uptake Transporters at the Blood–Brain Barrier and Their Role in Brain Drug Disposition. Pharmaceutics 2023, 15 (10) , 2473.
    26. Raymond K. Hau, Stephen H. Wright, Nathan J. Cherrington. Addressing the Clinical Importance of Equilibrative Nucleoside Transporters in Drug Discovery and Development. Clinical Pharmacology & Therapeutics 2023, 114 (4) , 780-794.
    27. Natascha Hartl, Bettina Gabold, Friederike Adams, Philipp Uhl, Sabrina Oerter, Sabine Gätzner, Marco Metzger, Ann-Christine König, Stefanie M. Hauck, Antje Appelt-Menzel, Walter Mier, Gert Fricker, Olivia M. Merkel. Overcoming the blood-brain barrier? - prediction of blood-brain permeability of hydrophobically modified polyethylenimine polyplexes for siRNA delivery into the brain with in vitro and in vivo models. Journal of Controlled Release 2023, 360 , 613-629.
    28. Dake Qi, Haiyang Lin, Bingying Hu, Yang Wei. A review on in vitro model of the blood-brain barrier (BBB) based on hCMEC/D3 cells. Journal of Controlled Release 2023, 358 , 78-97.
    29. Estrella Gonzales-Aloy, Aria Ahmed-Cox, Maria Tsoli, David S. Ziegler, Maria Kavallaris. From cells to organoids: The evolution of blood-brain barrier technology for modelling drug delivery in brain cancer. Advanced Drug Delivery Reviews 2023, 196 , 114777.
    30. David Gomez-Zepeda, Nicolas Perrière, Fabienne Glacial, Meryam Taghi, Cérina Chhuon, Jean-Michel Scherrmann, Philippe Sergent, Amélie Moreau, Claire Denizot, Yannick Parmentier, Salvatore Cisternino, Xavier Decleves, Marie-Claude Menet. Functional and targeted proteomics characterization of a human primary endothelial cell model of the blood-brain barrier (BBB) for drug permeability studies. Toxicology and Applied Pharmacology 2023, 465 , 116456.
    31. Li Di. Special issue on applications of in vitro, in vivo, and modeling and simulation tools for central nervous system drug disposition. Biopharmaceutics & Drug Disposition 2023, 44 (1) , 3-6.
    32. Pablo Torres-Vergara, Robin Rivera, Carlos Escudero, Jeffrey Penny. Maternal and Fetal Expression of ATP-Binding Cassette and Solute Carrier Transporters Involved in the Brain Disposition of Drugs. 2023, 149-177.
    33. Grace V. Aquino, Amjad Dabi, Gabriel J. Odom, Ramon Lavado, Kaitlin Nunn, Kathryn Thomas, Bennett Schackmuth, Nazeel Shariff, Manogna Jarajapu, Morgan Pluto, Sara R. Miller, Leah Eller, Justin Pressley, Rishi R. Patel, Jeffrey Black, Erica D. Bruce. Evaluating the effect of acute diesel exhaust particle exposure on P-glycoprotein efflux transporter in the blood–brain barrier co-cultured with microglia. Current Research in Toxicology 2023, 4 , 100107.
    34. Kaoru Sato, Michiya Matsusaki. MPS for Blood Brain Barrier. YAKUGAKU ZASSHI 2023, 143 (1) , 45-53.
    35. Nina Choublier, Meryam Taghi, Marie-Claude Menet, Morgane Le Gall, Johanna Bruce, Philippe Chafey, François Guillonneau, Amélie Moreau, Claire Denizot, Yannick Parmentier, Samir Nakib, Didier Borderie, Haniaa Bouzinba-Segard, Pierre-Olivier Couraud, Sandrine Bourdoulous, Xavier Declèves. Exposure of human cerebral microvascular endothelial cells hCMEC/D3 to laminar shear stress induces vascular protective responses. Fluids and Barriers of the CNS 2022, 19 (1)
    36. Marie-Pierre Dehouck, Masanori Tachikawa, Yutaro Hoshi, Kotaro Omori, Claude-Alain Maurage, Guillaume Strecker, Lucie Dehouck, Marie-Christine Boucau, Yasuo Uchida, Fabien Gosselet, Tetsuya Terasaki, Yannis Karamanos. Quantitative Targeted Absolute Proteomics for Better Characterization of an In Vitro Human Blood–Brain Barrier Model Derived from Hematopoietic Stem Cells. Cells 2022, 11 (24) , 3963.
    37. Yu Sakurai, Himeka Watanabe, Kazuma Nishio, Kohei Hashimoto, Atsuki Harada, Masaki Gomi, Masayoshi Suzuki, Ryotaro Oyama, Takumi Handa, Risa Sato, Hina Takeuchi, Ryoga Taira, Kenta Tezuka, Kota Tange, Yuta Nakai, Hidetaka Akita, Yasuo Uchida. pH-Responsive Lipid Nanoparticles Achieve Efficient mRNA Transfection in Brain Capillary Endothelial Cells. Pharmaceutics 2022, 14 (8) , 1560.
    38. Hinako Nagano, Shingo Ito, Takeshi Masuda, Sumio Ohtsuki. Effect of Insulin Receptor-Knockdown on the Expression Levels of Blood–Brain Barrier Functional Proteins in Human Brain Microvascular Endothelial Cells. Pharmaceutical Research 2022, 39 (7) , 1561-1574.
    39. Kristiina M. Huttunen, Tetsuya Terasaki, Arto Urtti, Ahmed B. Montaser, Yasuo Uchida. Pharmacoproteomics of Brain Barrier Transporters and Substrate Design for the Brain Targeted Drug Delivery. Pharmaceutical Research 2022, 39 (7) , 1363-1392.
    40. Moeno Kadoguchi, Hiroshi Arakawa, Ryokichi Honda, Kazuki Hotta, Yoshiyuki Shirasaka, Yoshiharu Deguchi, Ikumi Tamai. Characterization of Aripiprazole Uptake Transporter in the Blood-Brain Barrier Model hCMEC/D3 Cells by Targeted siRNA Screening. Pharmaceutical Research 2022, 39 (7) , 1549-1559.
    41. Toshiki Kurosawa, Daiki Sako, Yuma Tega, Yasuyuki Debori, Yumi Tomihara, Kazunobu Aoyama, Yoshiyuki Kubo, Nobuyuki Amano, Yoshiharu Deguchi. Construction and Functional Evaluation of a Three-Dimensional Blood–Brain Barrier Model Equipped With Human Induced Pluripotent Stem Cell-Derived Brain Microvascular Endothelial Cells. Pharmaceutical Research 2022, 39 (7) , 1535-1547.
    42. Deepak Ahire, Laken Kruger, Sheena Sharma, Vijaya Saradhi Mettu, Abdul Basit, Bhagwat Prasad, . Quantitative Proteomics in Translational Absorption, Distribution, Metabolism, and Excretion and Precision Medicine. Pharmacological Reviews 2022, 74 (3) , 771-798.
    43. Patrick T. Ronaldson, Thomas P. Davis. Transport Mechanisms at the Blood–Brain Barrier and in Cellular Compartments of the Neurovascular Unit: Focus on CNS Delivery of Small Molecule Drugs. Pharmaceutics 2022, 14 (7) , 1501.
    44. Hinako Nagano, Seiryo Ogata, Shingo Ito, Takeshi Masuda, Sumio Ohtsuki. Knockdown of Podocalyxin Post-Transcriptionally Induces the Expression and Activity of ABCB1/MDR1 in Human Brain Microvascular Endothelial Cells. Journal of Pharmaceutical Sciences 2022, 111 (6) , 1812-1819.
    45. William M. Pardridge. A Historical Review of Brain Drug Delivery. Pharmaceutics 2022, 14 (6) , 1283.
    46. Lushan Wang, Timothy S. Wiedmann, Karunya K. Kandimalla. Modulating insulin signaling and trafficking at the blood-brain barrier endothelium using lipid based nanoemulsions. International Journal of Pharmaceutics 2022, 622 , 121823.
    47. Dirk Gründemann, Lea Hartmann, Svenja Flögel. The ergothioneine transporter (ETT): substrates and locations, an inventory. FEBS Letters 2022, 596 (10) , 1252-1269.
    48. Takahiro Ishimoto, Yukio Kato. Ergothioneine in the brain. FEBS Letters 2022, 596 (10) , 1290-1298.
    49. Vishal Sangha, Erica I. Williams, Patrick T. Ronaldson, Reina Bendayan. DRUG TRANSPORT IN THE BRAIN. 2022, 283-317.
    50. Viktor Balzer, Pascal Poc, Elena Puris, Stefan Martin, Maryam Aliasgari, Seppo Auriola, Gert Fricker. Re-evaluation of the hCMEC/D3 based in vitro BBB model for ABC transporter studies. European Journal of Pharmaceutics and Biopharmaceutics 2022, 173 , 12-21.
    51. Kelsy L. Nilles, Erica I. Williams, Robert D. Betterton, Thomas P. Davis, Patrick T. Ronaldson. Blood–Brain Barrier Transporters: Opportunities for Therapeutic Development in Ischemic Stroke. International Journal of Molecular Sciences 2022, 23 (3) , 1898.
    52. Shingo Ito, Takeshi Masuda, Sumio Ohtsuki. Quantitative and Targeted Proteomics of the Blood-Brain Barrier: Species and Cell Line Differences. 2022, 123-139.
    53. Mehdi Taslimifar, Martin Faltys, Vartan Kurtcuoglu, François Verrey, Victoria Makrides. Analysis of L-leucine amino acid transporter species activity and gene expression by human blood brain barrier hCMEC/D3 model reveal potential LAT1, LAT4, B 0 AT2 and y + LAT1 functional cooperation. Journal of Cerebral Blood Flow & Metabolism 2022, 42 (1) , 90-103.
    54. Hussein Akel, Ildikó Csóka, Rita Ambrus, Alexandra Bocsik, Ilona Gróf, Mária Mészáros, Anikó Szecskó, Gábor Kozma, Szilvia Veszelka, Mária A. Deli, Zoltán Kónya, Gábor Katona. In Vitro Comparative Study of Solid Lipid and PLGA Nanoparticles Designed to Facilitate Nose-to-Brain Delivery of Insulin. International Journal of Molecular Sciences 2021, 22 (24) , 13258.
    55. Kei Higuchi, Sathish Sivaprakasam, Souad R. Sennoune, Jiro Ogura, Yangzom D. Bhutia, Ricardo Rueda, Suzette L. Pereira, Vadivel Ganapathy. A Proton-Coupled Transport System for β-Hydroxy-β-Methylbutyrate (HMB) in Blood–Brain Barrier Endothelial Cell Line hCMEC/D3. Nutrients 2021, 13 (9) , 3220.
    56. Leah A. Marquez-Curtis, Reid Bokenfohr, Locksley E. McGann, Janet A. W. Elliott, . Cryopreservation of human cerebral microvascular endothelial cells and astrocytes in suspension and monolayers. PLOS ONE 2021, 16 (4) , e0249814.
    57. Guinever Eustaquio Do Imperio, Phetcharawan Lye, Enrrico Bloise, Stephen G. Matthews. Function of Multidrug Resistance Transporters is Disrupted by Infection Mimics in Human Brain Endothelial Cells. Tissue Barriers 2021, 9 (2) , 1860616.
    58. Yasuo Uchida. Quantitative Proteomics-Based Blood–Brain Barrier Study. Biological and Pharmaceutical Bulletin 2021, 44 (4) , 465-473.
    59. Tetsuya Terasaki. Development of Novel Methodology and Its Application for Clarifying the Transport Function of the Blood-brain Barrier. YAKUGAKU ZASSHI 2021, 141 (4) , 447-462.
    60. Laurens F. M. Verscheijden, Carlijn H. C. Litjens, Jan B. Koenderink, Ron H. J. Mathijssen, Marcel M. Verbeek, Saskia N. de Wildt, Frans G. M. Russel, . Physiologically based pharmacokinetic/pharmacodynamic model for the prediction of morphine brain disposition and analgesia in adults and children. PLOS Computational Biology 2021, 17 (3) , e1008786.
    61. Takeshi Masuda, Ayano Mori, Shingo Ito, Sumio Ohtsuki. Quantitative and targeted proteomics-based identification and validation of drug efficacy biomarkers. Drug Metabolism and Pharmacokinetics 2021, 36 , 100361.
    62. Patrick T. Ronaldson, Hrvoje Brzica, Wazir Abdullahi, Bianca G. Reilly, Thomas P. Davis. Transport Properties of Statins by Organic Anion Transporting Polypeptide 1A2 and Regulation by Transforming Growth Factor- β Signaling in Human Endothelial Cells. Journal of Pharmacology and Experimental Therapeutics 2021, 376 (2) , 148-160.
    63. Kandarp M. Dave, Wanzhu Zhao, Catherine Hoover, Anisha D’Souza, Devika S Manickam. Extracellular Vesicles Derived from a Human Brain Endothelial Cell Line Increase Cellular ATP Levels. AAPS PharmSciTech 2021, 22 (1)
    64. Ryoma Yokoyama, Toru Taharabaru, Takumi Nishida, Yoshitaka Ohno, Yuki Maeda, Masahiro Sato, Kandai Ishikura, Kazunori Yanagihara, Hiroki Takagi, Teruya Nakamura, Shingo Ito, Sumio Ohtsuki, Hidetoshi Arima, Risako Onodera, Taishi Higashi, Keiichi Motoyama. Lactose-appended β-cyclodextrin as an effective nanocarrier for brain delivery. Journal of Controlled Release 2020, 328 , 722-735.
    65. Young-Sun Lee, Ji-Young Choi, Sakulrat Mankhong, Sohee Moon, Sujin Kim, Young Ho Koh, Ji-Hye Kim, Ju-Hee Kang. Sirtuin 1-dependent regulation of high mobility box 1 in hypoxia–reoxygenated brain microvascular endothelial cells: roles in neuronal amyloidogenesis. Cell Death & Disease 2020, 11 (12)
    66. Anna Gerhartl, Nadja Pracser, Alexandra Vladetic, Sabrina Hendrikx, Heinz-Peter Friedl, Winfried Neuhaus. The pivotal role of micro-environmental cells in a human blood–brain barrier in vitro model of cerebral ischemia: functional and transcriptomic analysis. Fluids and Barriers of the CNS 2020, 17 (1)
    67. Birthe Gericke, Kerstin Römermann, Andreas Noack, Sandra Noack, Jessica Kronenberg, Ingolf Ernst Blasig, Wolfgang Löscher. A face-to-face comparison of claudin-5 transduced human brain endothelial (hCMEC/D3) cells with porcine brain endothelial cells as blood–brain barrier models for drug transport studies. Fluids and Barriers of the CNS 2020, 17 (1)
    68. Lanxin Qiao, Yu Qin, Yaxin Wang, Yi Liang, Dunwan Zhu, Wei Xiong, Lu Li, Di Bao, Linhua Zhang, Xu Jin. A brain glioma gene delivery strategy by angiopep-2 and TAT-modified magnetic lipid-polymer hybrid nanoparticles. RSC Advances 2020, 10 (68) , 41471-41481.
    69. Julia Tschirka, Markus Bach, Ilmars Kisis, Julia Lemmen, Mark Jean Gnoth, Dirk Gründemann. Transporter tandems: precise tools for normalizing active transporter in the plasma membrane. Biochemical Journal 2020, 477 (21) , 4191-4206.
    70. Huilong Luo, Bruno Saubamea, Stéphanie Chasseigneaux, Véronique Cochois, Maria Smirnova, Fabienne Glacial, Nicolas Perrière, Catarina Chaves, Salvatore Cisternino, Xavier Declèves. Molecular and Functional Study of Transient Receptor Potential Vanilloid 1-4 at the Rat and Human Blood–Brain Barrier Reveals Interspecies Differences. Frontiers in Cell and Developmental Biology 2020, 8
    71. Solène Marie, Nicolas Tournier. Imagerie TEP pour l’étude des répercussions fonctionnelles de la P-glycoprotéine en neuropharmacocinétique. Therapies 2020, 75 (6) , 623-632.
    72. A. Wünsch, D. Mulac, K. Langer. Lipoprotein imitating nanoparticles: Lecithin coating binds ApoE and mediates non-lysosomal uptake leading to transcytosis over the blood-brain barrier. International Journal of Pharmaceutics 2020, 589 , 119821.
    73. Catarina Chaves, Tuan-Minh Do, Céline Cegarra, Valérie Roudières, Sandrine Tolou, Gilbert Thill, Corinne Rocher, Michel Didier, Dominique Lesuisse. Non-Human Primate Blood–Brain Barrier and In Vitro Brain Endothelium: From Transcriptome to the Establishment of a New Model. Pharmaceutics 2020, 12 (10) , 967.
    74. L. F. M. Verscheijden, A. C. van Hattem, J. C. L. M. Pertijs, C. A. de Jongh, R. M. Verdijk, B. Smeets, J. B. Koenderink, F. G. M. Russel, S. N. de Wildt. Developmental patterns in human blood–brain barrier and blood–cerebrospinal fluid barrier ABC drug transporter expression. Histochemistry and Cell Biology 2020, 154 (3) , 265-273.
    75. Yutaro Hoshi, Yasuo Uchida, Takashi Kuroda, Masanori Tachikawa, Pierre-Olivier Couraud, Takashi Suzuki, Tetsuya Terasaki. Distinct roles of ezrin, radixin and moesin in maintaining the plasma membrane localizations and functions of human blood–brain barrier transporters. Journal of Cerebral Blood Flow & Metabolism 2020, 40 (7) , 1533-1545.
    76. Brahim Achour, Zubida M. Al-Majdoub, Amin Rostami-Hodjegan, Jill Barber. Mass Spectrometry of Human Transporters. Annual Review of Analytical Chemistry 2020, 13 (1) , 223-247.
    77. Jiapeng Li, Hao-Jie Zhu. Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS)-Based Proteomics of Drug-Metabolizing Enzymes and Transporters. Molecules 2020, 25 (11) , 2718.
    78. Shingo Ito, Mariko Oishi, Seiryo Ogata, Tatsuki Uemura, Pierre-Olivier Couraud, Takeshi Masuda, Sumio Ohtsuki. Identification of Cell-Surface Proteins Endocytosed by Human Brain Microvascular Endothelial Cells In Vitro. Pharmaceutics 2020, 12 (6) , 579.
    79. Shunsuke Yamaguchi, Shingo Ito, Takeshi Masuda, Pierre-Olivier Couraud, Sumio Ohtsuki. Novel cyclic peptides facilitating transcellular blood-brain barrier transport of macromolecules in vitro and in vivo. Journal of Controlled Release 2020, 321 , 744-755.
    80. Jiaojiao Cong, Yiling Ruan, Qinglin Lyu, Xiaohui Qin, Xinming Qi, Wenyuan Liu, Lifeng Kang, Junying Zhang, Chunyong Wu. A proton-coupled organic cation antiporter is involved in the blood-brain barrier transport of Aconitum alkaloids. Journal of Ethnopharmacology 2020, 252 , 112581.
    81. E. Jacqueroux, S. Hodin, S. Saib, Z. He, V. Bin, O. Delézay, X. Delavenne. Value of quantifying ABC transporters by mass spectrometry and impact on in vitro-to-in vivo prediction of transporter-mediated drug-drug interactions of rivaroxaban. European Journal of Pharmaceutics and Biopharmaceutics 2020, 148 , 27-37.
    82. Masanori Tachikawa, Ryo Akaogi, Ayaka Taii, Shin-ichi Akanuma, Yasuo Uchida, Tetsuya Terasaki. Distinct Transport Properties of Human Pannexin 1 and Connexin 32 Hemichannels. Journal of Pharmaceutical Sciences 2020, 109 (3) , 1395-1402.
    83. Masanori Tachikawa, Yosuke Kaneko, Sumio Ohtsuki, Yasuo Uchida, Michitoshi Watanabe, Hideo Ohtsuka, Tetsuya Terasaki. Targeted Proteomics-Based Quantitative Protein Atlas of Pannexin and Connexin Subtypes in Mouse and Human Tissues and Cancer Cell Lines. Journal of Pharmaceutical Sciences 2020, 109 (2) , 1161-1168.
    84. Yasuo Uchida, Ryohei Goto, Hina Takeuchi, Magdalena Łuczak, Takuya Usui, Masanori Tachikawa, Tetsuya Terasaki. Abundant Expression of OCT2, MATE1, OAT1, OAT3, PEPT2, BCRP, MDR1, and xCT Transporters in Blood-Arachnoid Barrier of Pig and Polarized Localizations at CSF- and Blood-Facing Plasma Membranes. Drug Metabolism and Disposition 2020, 48 (2) , 135-145.
    85. Yutaro Hoshi, Yasuo Uchida, Masanori Tachikawa, Sumio Ohtsuki, Pierre-Olivier Couraud, Takashi Suzuki, Tetsuya Terasaki. Oxidative stress-induced activation of Abl and Src kinases rapidly induces P-glycoprotein internalization via phosphorylation of caveolin-1 on tyrosine-14, decreasing cortisol efflux at the blood–brain barrier. Journal of Cerebral Blood Flow & Metabolism 2020, 40 (2) , 420-436.
    86. Jin-Ha Choi, Mallesh Santhosh, Jeong-Woo Choi. In Vitro Blood–Brain Barrier-Integrated Neurological Disorder Models Using a Microfluidic Device. Micromachines 2020, 11 (1) , 21.
    87. David Gomez-Zepeda, Méryam Taghi, Jean-Michel Scherrmann, Xavier Decleves, Marie-Claude Menet. ABC Transporters at the Blood–Brain Interfaces, Their Study Models, and Drug Delivery Implications in Gliomas. Pharmaceutics 2020, 12 (1) , 20.
    88. Laura Hellinen, Kazuki Sato, Mika Reinisalo, Heidi Kidron, Kirsi Rilla, Masanori Tachikawa, Yasuo Uchida, Tetsuya Terasaki, Arto Urtti. Quantitative Protein Expression in the Human Retinal Pigment Epithelium: Comparison Between Apical and Basolateral Plasma Membranes With Emphasis on Transporters. Investigative Opthalmology & Visual Science 2019, 60 (15) , 5022.
    89. Tomohiro Nishimura, Yuichiro Sano, Yu Takahashi, Saki Noguchi, Yasuo Uchida, Akinori Takagi, Takahiro Tanaka, Satomi Katakura, Emi Nakashima, Masanori Tachikawa, Tetsuo Maruyama, Tetsuya Terasaki, Masatoshi Tomi. Quantification of ENT1 and ENT2 Proteins at the Placental Barrier and Contribution of These Transporters to Ribavirin Uptake. Journal of Pharmaceutical Sciences 2019, 108 (12) , 3917-3922.
    90. Gayathri Nair Sekhar, Alice L. Fleckney, Sevda Tomova Boyanova, Huzefa Rupawala, Rachel Lo, Hao Wang, Doaa B. Farag, Khondaker Miraz Rahman, Martin Broadstock, Suzanne Reeves, Sarah Ann Thomas. Region-specific blood–brain barrier transporter changes leads to increased sensitivity to amisulpride in Alzheimer’s disease. Fluids and Barriers of the CNS 2019, 16 (1)
    91. Xiaofen Zhao, Yangfang Li, Kun Du, Yuqin Wu, Ling Liu, Shan Cui, Yan Zhang, Jin Gao, Richard F. Keep, Jianming Xiang, . Involvement of human and canine MRP1 and MRP4 in benzylpenicillin transport. PLOS ONE 2019, 14 (11) , e0225702.
    92. Xiao-wei Ding, Xia Sun, Xue-fang Shen, Yan Lu, Jia-qiang Wang, Zhi-rong Sun, Chang-hong Miao, Jia-wei Chen. Propofol attenuates TNF-α-induced MMP-9 expression in human cerebral microvascular endothelial cells by inhibiting Ca2+/CAMK II/ERK/NF-κB signaling pathway. Acta Pharmacologica Sinica 2019, 40 (10) , 1303-1313.
    93. Lina Bergman, Pablo Torres-Vergara, Jeffrey Penny, Johan Wikström, Maria Nelander, Jose Leon, Mary Tolcher, James M. Roberts, Anna-Karin Wikström, Carlos Escudero. Investigating Maternal Brain Alterations in Preeclampsia: the Need for a Multidisciplinary Effort. Current Hypertension Reports 2019, 21 (9)
    94. Yusuke Ochiai, Yasuo Uchida, Masanori Tachikawa, Pierre‐Olivier Couraud, Tetsuya Terasaki. Amyloid beta 25‐35 impairs docosahexaenoic acid efflux by down‐regulating fatty acid transport protein 1 (FATP1/SLC27A1) protein expression in human brain capillary endothelial cells. Journal of Neurochemistry 2019, 150 (4) , 385-401.
    95. Liwen Deng, Brady L. Spencer, Joshua A. Holmes, Rong Mu, Sara Rego, Thomas A. Weston, Yoonsung Hu, Glenda F. Sanches, Sunghyun Yoon, Nogi Park, Prescilla E. Nagao, Howard F. Jenkinson, Justin A. Thornton, Keun Seok Seo, Angela H. Nobbs, Kelly S. Doran, . The Group B Streptococcal surface antigen I/II protein, BspC, interacts with host vimentin to promote adherence to brain endothelium and inflammation during the pathogenesis of meningitis. PLOS Pathogens 2019, 15 (6) , e1007848.
    96. Sulay H. Patel, Omnia A. Ismaiel, William R. Mylott, Moucun Yuan, Kurt F. Hauser, MaryPeace McRae. Simultaneous determination of intracellular concentrations of tenofovir, emtricitabine, and dolutegravir in human brain microvascular endothelial cells using liquid chromatography-tandem mass spectrometry (LC-MS/MS). Analytica Chimica Acta 2019, 1056 , 79-87.
    97. David Gomez-Zepeda, Meryam Taghi, Maria Smirnova, Philippe Sergent, Wang-Qing Liu, Cerina Chhuon, Michel Vidal, Martin Picard, Elizabeth Thioulouse, Isabelle Broutin, Ida-Chiara Guerrera, Jean-Michel Scherrmann, Yannick Parmentier, Xavier Decleves, Marie-Claude Menet. LC–MS/MS-based quantification of efflux transporter proteins at the BBB. Journal of Pharmaceutical and Biomedical Analysis 2019, 164 , 496-508.
    98. Keith D. Rochfort, Philip M. Cummins. In Vitro Cell Models of the Human Blood-Brain Barrier: Demonstrating the Beneficial Influence of Shear Stress on Brain Microvascular Endothelial Cell Phenotype. 2019, 71-98.
    99. Yu Takahashi, Tomohiro Nishimura, Kei Higuchi, Saki Noguchi, Yuma Tega, Toshiki Kurosawa, Yoshiharu Deguchi, Masatoshi Tomi. Transport of Pregabalin Via L-Type Amino Acid Transporter 1 (SLC7A5) in Human Brain Capillary Endothelial Cell Line. Pharmaceutical Research 2018, 35 (12)
    100. Stephen B. Hladky, Margery A. Barrand. Elimination of substances from the brain parenchyma: efflux via perivascular pathways and via the blood–brain barrier. Fluids and Barriers of the CNS 2018, 15 (1)
    Load all citations

    Pair your accounts.

    Export articles to Mendeley

    Get article recommendations from ACS based on references in your Mendeley library.

    Pair your accounts.

    Export articles to Mendeley

    Get article recommendations from ACS based on references in your Mendeley library.

    You’ve supercharged your research process with ACS and Mendeley!

    STEP 1:
    Click to create an ACS ID

    Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.

    Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.

    Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.

    Your Mendeley pairing has expired. Please reconnect